# LDA and LMWH vs LDA Alone in High-risk Patients for Preeclampsia Prevention

Study · id `cardio:ct-nct07361679` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07361679](<https://clinicaltrials.gov/study/NCT07361679>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07361679

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

## Technical summary

Registry record NCT07361679. Randomized; no masking; primary purpose prevention. Start 2023-01-18 (actual); primary completion 2026-11-01 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 100 participants (enrolled count; ClinicalTrials.gov record NCT07361679, source copy `cardio:ctgov-nct07361679-2026-11-18`, retrieved 2026-11-18)
- Started: 2023-01-18 (actual) (ClinicalTrials.gov record NCT07361679, source copy `cardio:ctgov-nct07361679-2026-11-18`, retrieved 2026-11-18)
- Primary completion: 2026-11-01 (actual) (ClinicalTrials.gov record NCT07361679, source copy `cardio:ctgov-nct07361679-2026-11-18`, retrieved 2026-11-18)
- Completion: 2026-11-01 (actual) (ClinicalTrials.gov record NCT07361679, source copy `cardio:ctgov-nct07361679-2026-11-18`, retrieved 2026-11-18)
- Countries: Greece (ClinicalTrials.gov record NCT07361679, source copy `cardio:ctgov-nct07361679-2026-11-18`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07361679-2026-11-18`, retrieved 2026-11-18)

## The registry's words

- Brief title: LDA and LMWH vs LDA Alone in High-risk Patients for Preeclampsia Prevention
- Acronym: preGO
- Condition: Preeclampsia Severe
- Condition: Toxemia Of Pregnancy
- Condition: Preeclampsia
- Condition: Pregnancy Complications
- Condition: Hypertension, Pregnancy-Induced
- Condition: Gestational Hypertension
- Intervention (Drug): Aspirin
- Intervention (Drug): Tinzaparin
- Lead sponsor: Alexandra Hospital, Athens, Greece
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry intervention name matches this record: Aspirin (`core:aspirin`)

## Provenance

Content hash: aab98891a95ea0967714e197154b564a613ef135fccd9e47f82792feb446aa52
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
